Head/Neck Cancer

Top Story

Hypofractionated radiotherapy may improve glottic cancer survival

Hypofractionated radiotherapy may improve glottic cancer survival
June 27, 2017

Hypofractionated radiotherapy improved survival in patients with early-stage glottic cancer compared with conventionally fractionated radiotherapy, according to a study published in Journal of the National Cancer Institute.

“The study was prompted by controversy about whether using a hypofractionated radiation approach was superior to standard radiation approaches for early-stage glottic cancer,” Zain A. Husain, MD, assistant professor of therapeutic radiology and director of head and neck radiotherapy at Smilow Cancer Hospital, told HemOnc Today. “The National Comprehensive Cancer Network guidelines currently say both standard-fraction and hypofractionated options are accepted; however, previous randomized data did suggest a control benefit to hypofractionated radiation.”

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients

June 26, 2017
Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today. The venture is intended to further progress in cancer…
In the Journals Plus

Overall survival low with sorafenib treatment for anaplastic thyroid carcinoma

June 26, 2017
Adults with medullary thyroid carcinoma can be treated safely and effectively with sorafenib, but the agent is less effective for treatment of anaplastic thyroid…

Two-dose Cervarix HPV vaccine remains noninferior to three doses at 36 months

June 26, 2017
A two-dose regimen of the Cervarix HPV vaccine in girls remained noninferior to the three-dose regimen in young women 3 years after vaccination, according to…
CME

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »
Video
Meeting News

VIDEO: Role of adjuvant chemotherapy in nasopharynx cancer remains uncertain

June 19, 2017
More »
Featured

CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
In the Journals Plus

Hypofractionated radiotherapy may improve glottic cancer survival

June 27, 2017
Hypofractionated radiotherapy improved survival in patients with early-stage glottic cancer compared with conventionally fractionated radiotherapy…

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients

June 26, 2017
Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today. The venture is intended to further…

In the Journals Plus

Overall survival low with sorafenib treatment for anaplastic thyroid carcinoma

June 26, 2017
Adults with medullary thyroid carcinoma can be treated safely and effectively with sorafenib, but the agent is less effective for treatment of…

Two-dose Cervarix HPV vaccine remains noninferior to three doses at 36 months

June 26, 2017
A two-dose regimen of the Cervarix HPV vaccine in girls remained noninferior to the three-dose regimen in young women 3 years after vaccination…

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist…

Meeting NewsVideo

VIDEO: Role of adjuvant chemotherapy in nasopharynx cancer remains uncertain

June 19, 2017
CHICAGO — Barbara Ann Burtness, MD, professor of medicine at Yale Cancer Center and a HemOnc Today Editorial Board member, discusses the role…

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” …

Meeting News

Adjuvant chemotherapy shows no benefit in advanced nasopharyngeal carcinoma

June 15, 2017
CHICAGO — Adjuvant chemotherapy with cisplatin and gemcitabine failed to extend survival in high-risk patients with nasopharyngeal carcinoma…

Meeting NewsVideo

VIDEO: Speaker offers key takeaways in head and neck cancer from the ASCO Annual Meeting

June 15, 2017
CHICAGO — Barbara Ann Burtness, MD, professor of medicine at Yale Cancer Center and a HemOnc Today Editorial Board member, offers key takeaways…

Oral contraceptive use does not increase long-term cancer risk

June 14, 2017
Women who used oral contraceptives did not demonstrate increased long-term cancer risk, according to results of the Royal College of General…

More Headlines »
Advertisement
Advertisement